Suppr超能文献

术前静脉使用替诺昔康的效果:一项前瞻性、双盲、安慰剂对照研究。

The effect of preoperative intravenous use of tenoxicam: a prospective, double-blind, placebo-controlled study.

作者信息

Akca Tamer, Colak Tahsin, Kanik Arzu, Yaylak Faik, Caglikulekci Mehmet, Aydin Suha

机构信息

Department of General Surgery, Mersin University Medical Faculty, Mersin, Turkey.

出版信息

J Invest Surg. 2004 Nov-Dec;17(6):333-8. doi: 10.1080/08941930490524390.

Abstract

In this study, we aimed to investigate the postoperative pain relief effect of preoperative tenoxicam usage in patients who undergo elective laparoscopic cholecystectomy or groin hernia repair. Eighty patients undergoing laparoscopic cholecystectomy or groin hernia repair procedures were randomized to receive either physiologic serum at 100 mL (group I, n = 40) or 20 mg iv tenoxicam (group II, n = 40) immediately before induction. Postoperative analgesic requirement, peroperative side effects and complications of drugs, operating time, post-operative mobilization time and pain score, hospitalization time, and patient pleasure were recorded. Postoperative pain was assessed by the visual analogue scale (VAS) on the recovery unit (RU), at 4, 8, and 24 h and every day at the same times in the morning. The RU median VAS score was also not different when Group 1 was compared with Group 2 (p = .97). However, the postoperative 4-h and 8-h median VAS score was significantly less (p = .01 and p = .03, respectively); first postoperative mobilization time was earlier in group 2 (p = .32). The median pain score and intramuscular analgesic requirement of patients were also reduced in Group 2 in postoperative day 1 (p = .015). The median duration of intramuscular analgesic requirement and total amount of intramuscular analgesic used in patients were also significantly less in Group 2 (p = .0001 and p = .0001, respectively). Thus, this study showed that preoperative use of iv tenoxicam is safe, simple, and effective for postoperative pain relief after laparoscopic cholecystectomy or inguinal hernia repair.

摘要

在本研究中,我们旨在调查术前使用替诺昔康对接受择期腹腔镜胆囊切除术或腹股沟疝修补术患者术后疼痛缓解的效果。80例接受腹腔镜胆囊切除术或腹股沟疝修补术的患者被随机分组,在诱导前即刻分别接受100 mL生理血清(I组,n = 40)或20 mg静脉注射替诺昔康(II组,n = 40)。记录术后镇痛需求、药物的术中副作用和并发症、手术时间、术后活动时间和疼痛评分、住院时间以及患者满意度。在恢复病房(RU),于术后4、8和24小时以及每天上午同一时间,通过视觉模拟量表(VAS)评估术后疼痛。将I组与II组比较时,RU的VAS评分中位数也无差异(p = 0.97)。然而,术后4小时和8小时的VAS评分中位数显著更低(分别为p = 0.01和p = 0.03);II组术后首次活动时间更早(p = 0.32)。术后第1天,II组患者的疼痛评分中位数和肌肉注射镇痛需求也降低(p = 0.015)。II组患者肌肉注射镇痛需求的中位数持续时间和肌肉注射镇痛药物的总用量也显著更少(分别为p = 0.0001和p = 0.0001)。因此,本研究表明,术前静脉注射替诺昔康对于腹腔镜胆囊切除术或腹股沟疝修补术后的疼痛缓解是安全、简便且有效的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验